|
2023 Journal Article Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemiaEifert, Theresa, Hsu, Chen-Jen, Becker, Alicia L., Graessle, Sarah, Horne, Arik, Bemmann, Franziska, Zhang, Qirui, Heuser, Michael, Vasioukhin, Valeri, Scholl, Sebastian, Hochhaus, Andreas, Siegerist, Florian, Endlich, Nicole, Bullinger, Lars, Lane, Steven W., Haas, Simon, Schnoeder, Tina M. and Heidel, Florian H. (2023). Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia. Leukemia, 37 (10), 2027-2035. doi: 10.1038/s41375-023-02005-9 |
|
2023 Journal Article The TRIM31-paradox: an unexpected benefit for leukemia stem cellsStraube, Jasmin and Lane, Steven W. (2023). The TRIM31-paradox: an unexpected benefit for leukemia stem cells. Haematologica, 108 (8), 1982-1983. doi: 10.3324/haematol.2022.282622 |
|
2023 Journal Article Follow up of women after obstetric anal sphincter injuries (OASI)-what is the role of anorectal testing?Badri, Hawra, Fowler, Gillian and Lane, Steven (2023). Follow up of women after obstetric anal sphincter injuries (OASI)-what is the role of anorectal testing?. Neurourology and Urodynamics, 42 (6), 1374-1380. doi: 10.1002/nau.25220 |
|
2023 Journal Article Using technology to reduce critical deterioration (the DETECT study): a cost analysis of care costs at a tertiary children's hospital in the United KingdomCosta, Eduardo, Mateus, Ceu, Carter, Bernie, Saron, Holly, Eyton-Chong, Chin-Kien, Mehta, Fulya, Lane, Steven, Siner, Sarah, Dean, Jason, Barnes, Michael, McNally, Chris, Lambert, Caroline, Hollingsworth, Bruce, Carrol, Enitan D. D. and Sefton, Gerri (2023). Using technology to reduce critical deterioration (the DETECT study): a cost analysis of care costs at a tertiary children's hospital in the United Kingdom. BMC Health Services Research, 23 (1) 725, 1-10. doi: 10.1186/s12913-023-09739-3 |
|
2023 Journal Article Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentationIland, Harry J, Russell, Nigel H., Dillon, Richard, Schuh, Andre C., Tedjaseputra, Aditya, Wei, Andrew H., Khwaja, Asim, Knapper, Steven, Lane, Steven W, Reynolds, John, McMullin, Mary Frances Frances, Martin, Annalise Maria, Tan, Peter, Taussig, David Christopher C, Wong, Anny, Taper, John M, Fraga, Christina, Kelly, Richard, Tawana, Kiran, Mehta, Priyanka, Mina, Alain, Altman, Jessica K., Mølle, Ingolf, Tauro, Sudhir and Tholouli, Eleni (2023). Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation. Blood Advances, 7 (11), 2580-2585. doi: 10.1182/bloodadvances.2022007126 |
|
2023 Journal Article Shelter from the cytokine storm in myelofibrosisLane, Steven W. (2023). Shelter from the cytokine storm in myelofibrosis. Blood, 141 (20), 2415-2416. doi: 10.1182/blood.2023019779 |
|
2023 Journal Article Could an artificial intelligence approach to prior authorization be more human?Lenert, Leslie A., Lane, Steven and Wehbe, Ramsey (2023). Could an artificial intelligence approach to prior authorization be more human?. Journal of the American Medical Informatics Association, 30 (5), 989-994. doi: 10.1093/jamia/ocad016 |
|
2023 Journal Article Culturally adapted motivational interviewing with cognitive behavior therapy and mindfulness-based relapse prevention for substance use disorder in Pakistan (CAMAIB): protocol for a feasibility factorial randomised controlled trialAsif, Muqaddas, Khoso, Ameer B. B., Husain, M. Ali, Shahzad, Salman, Van Hout, Marie-Claire, Rafiq, Noor-ul-Zaman, Lane, Steven, Chaudhry, Imran Bashir and Husain, Nusrat (2023). Culturally adapted motivational interviewing with cognitive behavior therapy and mindfulness-based relapse prevention for substance use disorder in Pakistan (CAMAIB): protocol for a feasibility factorial randomised controlled trial. Pilot and Feasibility Studies, 9 (1) 67, 111. doi: 10.1186/s40814-023-01296-0 |
|
2023 Conference Publication A phase 2/3, multicenter trial of lenzilumab and azacitidine in chronic myelomonocytic leukemia: The PREACH-M trialHiwase, Devendra, Ross, David, Lane, Steven, Yong, Agnes, Sharplin, Kirsty, Yeung, David, Butler, Lisa, Chappell, Dale, Durrant, Cameron, Hughes, Timothy and Thomas, Daniel (2023). A phase 2/3, multicenter trial of lenzilumab and azacitidine in chronic myelomonocytic leukemia: The PREACH-M trial. 114th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Orlando Fl, Apr 14-19, 2023. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2023-CT085 |
|
2023 Journal Article Oncogenic drivers dictate immune control of acute myeloid leukemiaAustin, Rebecca J., Straube, Jasmin, Halder, Rohit, Janardhanan, Yashaswini, Bruedigam, Claudia, Witkowski, Matthew, Cooper, Leanne, Porter, Amy, Braun, Matthias, Souza-Fonseca-Guimaraes, Fernando, Minnie, Simone A., Cooper, Emily, Jacquelin, Sebastien, Song, Axia, Bald, Tobias, Nakamura, Kyohei, Hill, Geoffrey R., Aifantis, Iannis, Lane, Steven W. and Bywater, Megan J. (2023). Oncogenic drivers dictate immune control of acute myeloid leukemia. Nature Communications, 14 (1) 2155, 1-14. doi: 10.1038/s41467-023-37592-9 |
|
2023 Journal Article A mixed method, phase 2 clinical evaluation of a novel device to treat postpartum haemorrhageWeeks, Andrew D., Cunningham, Caroline, Taylor, Wendy, Rosala-Hallas, Anna, Watt, Peter, Bryning, Lucy, Ezeofor, Victory, Cregan, Liz, Hayden, Emma, Lambert, Dot, Bedwell, Carol, Lane, Steven, Fisher, Tony, Edwards, Rhiannon T. and Lavender, Tina (2023). A mixed method, phase 2 clinical evaluation of a novel device to treat postpartum haemorrhage. European Journal of Obstetrics and Gynecology and Reproductive Biology, 283, 142-148. doi: 10.1016/j.ejogrb.2023.01.018 |
|
2023 Journal Article Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemiaStraube, Jasmin, Eifert, Theresa, Vu, Therese, Janardhanan, Yashaswini, Haldar, Rohit, von Eyss, Björn, Cooper, Leanne, Bruedigam, Claudia, Ling, Victoria Y., Cooper, Emily, Patch, Ann-Marie, Bullinger, Lars, Schnoeder, Tina M., Bywater, Megan, Heidel, Florian H. and Lane, Steven W. (2023). Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia. Leukemia, 37 (4), 741-750. doi: 10.1038/s41375-023-01832-0 |
|
2023 Journal Article Real world molecular characterisation and clonal evolution of acute myeloid leukaemia reveals therapeutic opportunities and challengesNelles, Ricky, Seymour, Louise, Richmond, Joshua and Lane, Steven (2023). Real world molecular characterisation and clonal evolution of acute myeloid leukaemia reveals therapeutic opportunities and challenges. Pathology, 55 (1), 64-70. doi: 10.1016/j.pathol.2022.07.019 |
|
2023 Journal Article t(15;17) in acute promyelocytic leukemiaLing, Victoria Y. and Lane, Steven W. (2023). t(15;17) in acute promyelocytic leukemia. Haematologica, 108 (2), 295-296. doi: 10.3324/haematol.2022.282577 |
|
2023 Conference Publication Minocycline and/or omega-3 fatty acids added to treatment as usual for individuals with at risk mental states. A large multicenter double blind RCTQurashi, I., Chaudhry, B., Khoso, B. A., Husain, M. O., Hafeez, D., Kiran, T., Lane, S., Naqvi, A. H., Minhas, A. F., Nizami, T. A., Razzaque, B., Bokhari, Q. S., Yung, R. A., Deakin, B. and Husain, N. (2023). Minocycline and/or omega-3 fatty acids added to treatment as usual for individuals with at risk mental states. A large multicenter double blind RCT. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. doi: 10.1016/j.jpsychores.2023.111238 |
|
2023 Conference Publication Immunoproteasome Function Maintains Oncogenic Gene Expression In Kmt2a-complex Driven LeukemiaHeidel, Florian, Tubio-Santamaria, Nuria, Jayavelu, Ashok Kumar, Schnoeder, Tina, Eifert, Theresa, Hsu, Chen-Jen, Perner, Florian, Zhang, Qirui, Wenge, Daniela, Hansen, Fynn, Jyotsana, Nidhi, Lane, Steven, von Eyss, Björn, Deshpande, Aniruddha, Kühn, Michael, Schwaller, Jürg, Ebstein, Frederic, Krüger, Elke, Hochhaus, Andreas, Heuser, Michael, Ori, alessandro, Mann, Matthias and Armstrong, Scott (2023). Immunoproteasome Function Maintains Oncogenic Gene Expression In Kmt2a-complex Driven Leukemia. 2023 Annual Scientific Meeting of the ISEH – International Society for Experimental Hematology, New York, NY United States, 17-20 August 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.exphem.2023.06.049 |
|
2023 Journal Article Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemiaLing, Victoria Y., Straube, Jasmin, Godfrey, William, Haldar, Rohit, Janardhanan, Yashaswini, Cooper, Leanne, Bruedigam, Claudia, Cooper, Emily, Tavakoli Shirazi, Paniz, Jacquelin, Sebastien, Tey, Siok-Keen, Baell, Jonathan, Huang, Fei, Jin, Jianwen, Zhao, Yichao, Bullinger, Lars, Bywater, Megan J. and Lane, Steven W. (2023). Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia. Leukemia, 37 (1), 143-153. doi: 10.1038/s41375-022-01755-2 |
|
2022 Journal Article The importance of pore-forming toxins in multiple organ injury and dysfunctionAbrams, Simon T. T., Wang, Lijun, Yong, Jun, Yu, Qian, Du, Min, Alhamdi, Yasir, Cheng, Zhenxing, Dart, Caroline, Lane, Steven, Yu, Weiping, Toh, Cheng-Hock and Wang, Guozheng (2022). The importance of pore-forming toxins in multiple organ injury and dysfunction. Biomedicines, 10 (12) 3256, 1-15. doi: 10.3390/biomedicines10123256 |
|
2022 Conference Publication Imetelstat-Mediated Alterations in Lipid Metabolism to Induce Ferroptosis As Therapeutic Strategy for Acute Myeloid LeukemiaBruedigam, Claudia, Porter, Amy H., Song, Axia, Vroeg in de Wei, Gerjanne, Stoll, Thomas, Straube, Jasmin, Cooper, Leanne T., Cheng, Guidan, Kahl, Vivian F.S., Sobinoff, Alexander, Ling, Victoria Y., Jebaraj, Billy Michael Chelliah, Bray, Laura J., Bullinger, Lars, Heidel, Florian H., Kennedy, Glen A., Hill, Michelle M., Pickett, Hilda, Abdel-Wahab, Omar, Hartel, Gunter and Lane, Steven W. (2022). Imetelstat-Mediated Alterations in Lipid Metabolism to Induce Ferroptosis As Therapeutic Strategy for Acute Myeloid Leukemia. 64th ASH Annual Meeting, New Orleans, LA United States, 10-13 December 2022. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2022-168166 |
|
2022 Conference Publication A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Essential Thrombocythemia (ET)Gill, Harinder, Palandri, Francesca, Ross, David M., Cochrane, Tara, Tate, Courtney, Lane, Steven W., Larsen, Stephen R., Gerds, Aaron T., Halpern, Anna B., Shortt, Jake, Rossetti, James M., Pettit, Kristen M., Liang, James, Mead, Adam J., Marchetti, Monia, Vannucchi, Alessandro M., Wilson, Andrew J., Goethert, Joachim R., Hanna, Merit, Passamonti, Francesco, Stevenson, William S., Harrison, Claire, Talpaz, Moshe, Vianelli, Nicola and Rienhoff, Hugh Young (2022). A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Essential Thrombocythemia (ET). 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans La, Dec 10-13, 2022. AMSTERDAM: ELSEVIER. doi: 10.1182/blood-2022-159047 |
